L-Carvone

L-Carvone

SCHEMBL230994

C=C(C)[C@@H]1CC=C(C)C(=O)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
LMNA P02545 5/20 0.47
TSHR P16473 3/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 2/20 0.42
TGFBR1 P36897 1/20 0.42
TRPA1 O75762 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 1/20 0.41
ALOX12 P18054 1/20 0.41
CYP1B1 Q16678 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(S)(+)Carvone SCHEMBL184022 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL2036234 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL39408 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL18305510 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL19899318 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL6064886 0.98 ALDH1A1 (0.96) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL8600324 0.98 ALDH1A1 (0.96) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL10687915 0.98 ALDH1A1 (0.96) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL2794415 0.98 ALDH1A1 (0.96) ALDH1A1MEN1KMT2ALMNATSHR
Carvone SCHEMBL7588834 0.98 ALDH1A1 (0.96) ALDH1A1MEN1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2410 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12635710-B2 Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions EASTMAN CHEMICAL COMPANY (US) 2026-05-26 US claimed
CN-122010867-A L-carvone hydrazone derivative and application thereof 南京农业大学 2026-05-12 CN claimed
US-12595435-B2 Detergent compositions THE PROCTER & GAMBLE COMPANY (US) 2026-04-07 US claimed
EP-4715006-A2 UNSATURATED SCORCH RETARDERS Nouryon Chemicals International B.V. (NL) 2026-03-25 EP claimed
US-20260078088-A1 UNSATURATED SCORCH RETARDERS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2026-03-19 US claimed
EP-4710766-A1 MIXTURES OF AMBRUTICIN WITH AT LEAST ONE FURTHER PESTICIDE BASF SE (DE) 2026-03-18 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
US-20260043010-A1 ENONE REDUCTASES CODEXIS, INC. (US) 2026-02-12 US claimed
EP-4208023-B1 METHOD FOR PROTECTING PLANT PRODUCTS DURING TRANSPORT, AND CORRESPONDING TREATMENT DEVICE XEDA INTERNATIONAL (FR) 2026-02-11 EP claimed
EP-4687452-A1 ESSENTIAL OIL IMPREGNATED DEVICE AND METHODS OF USE THEREOF Pertinent Eco-Solutions Inc. (US) 2026-02-11 EP claimed
CN-104955934-A Treatment compositions comprising microcapsules, primary or secondary amines, and formaldehyde scavengers PROCTER & GAMBLE 2015-09-30 CN claimed
EP-2919773-A1 METHODS OF TREATMENT OF KERATINOCYTE-DERIVED LESIONS The Trustees of Columbia University in the City of New York (US) 2015-09-23 EP claimed
WO-2014116469-A1 TREATMENT COMPOSITIONS COMPRISING MICROCAPSULES, PRIMARY OR SECONDARY AMINES, AND FORMALDEHYDE SCAVENGERS THE PROCTER & GAMBLE COMPANY (US) 2014-07-31 WO claimed
US-20140201927-A1 TREATMENT COMPOSITIONS COMPRISING MICROCAPSULES, PRIMARY OR SECONDARY AMINES, and FORMALDEHYDE SCAVENGERS THE PROCTER & GAMBLE COMPANY (US) 2014-07-24 US claimed
EP-2757146-A1 Treatment compositions comprising microcapsules, primary or secondary amines, and formaldehyde scavengers The Procter & Gamble Company (US) 2014-07-23 EP claimed
WO-2014078868-A1 METHODS OF TREATMENT OF KERATINOCYTE-DERIVED LESIONS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-05-22 WO claimed
EP-2368547-B1 Antiviral compositions comprising geraniol and carvone CESA ALLIANCE SA (LU) 2012-09-12 EP claimed
WO-2012012498-A9 USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS PULMATRIX, INC. (US) 2012-04-05 WO claimed
WO-2012012498-A2 USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS PULMATRIX, INC. (US) 2012-01-26 WO claimed
EP-2368547-A1 Antiviral compositions comprising geraniol and carvone Cesa Alliance S.A. (LU) 2011-09-28 EP claimed